Understanding how lysosomes repair themselves through lipid changes
Lysosomal quality control through lipid remodeling
This study is looking at how tiny parts of our cells called lysosomes help keep our cells healthy and fix themselves when they get damaged, especially as we age or face certain diseases, and it hopes to find new ways to help improve their function for better overall health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10918080 on NIH RePORTER |
What this research studies
This research investigates the role of lysosomes in cell health and their ability to repair themselves when damaged. It focuses on how lysosomal dysfunction is linked to aging and various diseases, including cardiovascular issues and neurodegeneration. By exploring a newly discovered pathway that helps lysosomes recover from damage, the research aims to identify potential therapeutic targets that could enhance cellular repair mechanisms. Patients may benefit from insights into how to improve lysosomal function and overall cellular health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing age-related diseases or conditions linked to lysosomal dysfunction, such as cardiovascular diseases.
Not a fit: Patients with conditions unrelated to lysosomal function or those who are not experiencing age-related cellular stress may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases associated with lysosomal dysfunction, improving patient outcomes.
How similar studies have performed: Other research has shown promise in understanding lysosomal function and repair mechanisms, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Tan, Xiaojun — University of Pittsburgh at Pittsburgh
- Study coordinator: Tan, Xiaojun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.